BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 22406537)

  • 1. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.
    Deane R; Singh I; Sagare AP; Bell RD; Ross NT; LaRue B; Love R; Perry S; Paquette N; Deane RJ; Thiyagarajan M; Zarcone T; Fritz G; Friedman AE; Miller BL; Zlokovic BV
    J Clin Invest; 2012 Apr; 122(4):1377-92. PubMed ID: 22406537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted inhibition of RAGE reduces amyloid-β influx across the blood-brain barrier and improves cognitive deficits in db/db mice.
    Wang H; Chen F; Du YF; Long Y; Reed MN; Hu M; Suppiramaniam V; Hong H; Tang SS
    Neuropharmacology; 2018 Mar; 131():143-153. PubMed ID: 29248482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid-β Metabolism and AGEs-Induced Inflammation and Oxidative Stress in Rat Hippocampus.
    Hong Y; Shen C; Yin Q; Sun M; Ma Y; Liu X
    Neurochem Res; 2016 May; 41(5):1192-9. PubMed ID: 26738988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.
    Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF
    Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
    Neumann U; Rueeger H; Machauer R; Veenstra SJ; Lueoend RM; Tintelnot-Blomley M; Laue G; Beltz K; Vogg B; Schmid P; Frieauff W; Shimshek DR; Staufenbiel M; Jacobson LH
    Mol Neurodegener; 2015 Sep; 10():44. PubMed ID: 26336937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lipoprotein receptor cluster IV mutant preferentially binds amyloid-β and regulates its clearance from the mouse brain.
    Sagare AP; Bell RD; Srivastava A; Sengillo JD; Singh I; Nishida Y; Chow N; Zlokovic BV
    J Biol Chem; 2013 May; 288(21):15154-66. PubMed ID: 23580652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid β peptide-mediated neuronal disorder.
    Cai C; Dai X; Zhu Y; Lian M; Xiao F; Dong F; Zhang Q; Huang Y; Zheng Q
    Appl Microbiol Biotechnol; 2016 Jan; 100(2):825-35. PubMed ID: 26496918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease.
    Zhou R; Chen LL; Yang H; Li L; Liu J; Chen L; Hong WJ; Wang CG; Ma JJ; Huang J; Zhou XF; Liu D; Zhou HD
    Curr Alzheimer Res; 2021; 18(5):428-442. PubMed ID: 34488598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAGE-Specific Inhibitor FPS-ZM1 Attenuates AGEs-Induced Neuroinflammation and Oxidative Stress in Rat Primary Microglia.
    Shen C; Ma Y; Zeng Z; Yin Q; Hong Y; Hou X; Liu X
    Neurochem Res; 2017 Oct; 42(10):2902-2911. PubMed ID: 28664403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
    Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
    J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
    Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling.
    Park R; Kook SY; Park JC; Mook-Jung I
    Cell Death Dis; 2014 Jun; 5(6):e1299. PubMed ID: 24967961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking and Molecular Dynamics-Based Identification of Interaction between Various Beta-Amyloid Isoforms and RAGE Receptor.
    Tolstova AP; Adzhubei AA; Mitkevich VA; Petrushanko IY; Makarov AA
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.
    Cho HJ; Son SM; Jin SM; Hong HS; Shin DH; Kim SJ; Huh K; Mook-Jung I
    FASEB J; 2009 Aug; 23(8):2639-49. PubMed ID: 19332646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer's model.
    Hanafy AS; Lamprecht A; Dietrich D
    Fluids Barriers CNS; 2023 Nov; 20(1):85. PubMed ID: 37993886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
    Lue LF; Yan SD; Stern DM; Walker DG
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.
    Carnevale D; Mascio G; D'Andrea I; Fardella V; Bell RD; Branchi I; Pallante F; Zlokovic B; Yan SS; Lembo G
    Hypertension; 2012 Jul; 60(1):188-97. PubMed ID: 22615109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.
    Guo YX; He LY; Zhang M; Wang F; Liu F; Peng WX
    Neuroscience; 2016 May; 322():28-38. PubMed ID: 26820600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for advanced glycation end-product antagonist reduces blood-brain barrier damage after intracerebral hemorrhage.
    Yang F; Wang Z; Zhang JH; Tang J; Liu X; Tan L; Huang QY; Feng H
    Stroke; 2015 May; 46(5):1328-36. PubMed ID: 25782468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.